Antifungal Flavonoids from Hildegardia barteri

Tamara L. Meragelman, Kenneth D. Tucker,§ Thomas G. McCloud, John H. Cardellina II,* and Robert H. Shoemaker
Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, and SAIC-Frederick, Inc., National Cancer Institute-Frederick, Frederick, Maryland 21702-1201
J. Nat. Prod., 2005, 68 (12), pp 1790–1792
DOI: 10.1021/np0503000
Publication Date (Web): December 2, 2005
Copyright Not subject to U.S. Copyright. Published 2005 American Chemical Society and American Society of Pharmacognosy

 Screening Technologies Branch.

,

 SAIC-Frederick, Inc.

,
§

 Current address:  NBACC, 7435 New Technology Way, Frederick, MD 21703.

,
*

 To whom correspondence should be addressed. Tel:  301-846-1121. Fax:  301-846-6775. E-mail:  jcardellina@ncifcrf.gov.

Abstract

Abstract Image

A new isoflavan, (3R)-6,2‘-dihydroxy-7-methoxy-4‘,5‘-methylenedioxyisoflavan, hildegardiol (1), and two known flavonoids, 2-hydroxymaackiain (2) and farrerol (3), were isolated from the antifungal root extract of Hildegardia barteri. The pterocarpan 2 was largely responsible for the observed antifungal activity.

Tools

History

  • Published In Issue December 26, 2005
  • Received August 16, 2005

Recommend & Share

Related Content

Other ACS content by these authors: